A coming tsunami of mRNA medicines - Health Alliance Australia

A coming tsunami of mRNA medicines

“There is a coming tsunami of mRNA medicines” Melissa J Moore, PhD and Chief Health Officer for Moderna.

“It took our mRNA design team just one hour to design, that we immediately (**audience applauses**) put onto our manufacturing equipment. We were then able to make the mRNA, get it quality controlled, finished and shipped off to NIH for the clinical trials in 45 days. What I find truly remarkable is that mRNA sequence that took us 1 hour to design is the same mRNA that went into your arms. One hour to design a medicine that has saved countless lives”

Melissa says that she found 175 clinic trials of mRNA based medicine and 54 waiting in the wings on clinicaltrials.gov. She discusses how patients having open heart surgery had mRNA directly injected into their heart muscles that told their heart to grow near blood vessels in order to get around clogged arteries. She discusses treating cancer patients with personalized cancer vaccines that attack cancer cells and how mRNA can be used to treat metabolic and genetic diseases.

Many people will be shocked to learn that the COVID19 “vaccine” was designed in 1 hour!!

Watch video below

Australian Investment in mRNA

“Australia’s RNA sector was recently bolstered by the Government’s 10-year strategic partnership with Moderna and the Victorian Government to establish an onshore mRNA manufacturing facility in Melbourne.

The Victorian, New South Wales, Queensland and South Australian governments are also actively investing in the RNA sector.

The Government is also targeting $1.5 billion through the National Reconstruction Fund (NRF) for medical manufacturing, $1 billion for advanced manufacturing and a further $1 billion for critical technologies – sectors that can include biotechnologies.

Biotechnologies are also one of the seven key enabling technologies in the Australian Government’s Critical Technologies List.

DISR’s consultation is open until 16 October 2023,

“The department wants to understand the challenges and opportunities for developing Australia’s ribonucleic acid (RNA) sector.

The government would like to hear about what you think is currently working well within Australia’s RNA sector, and what could be improved.

Your feedback will:

  • give us insights into Australia’s RNA sector capabilities and priorities for the next 10 years
  • help them understand the opportunities and challenges for growth of the RNA sector in Australia.

and the discussion paper is available at https://consult.industry.gov.au/rnadiscussion

Source https://www.minister.industry.gov.au/ministers/husic/media-releases/understanding-australias-rna-potential

According to the discussion paper,

“mRNA vaccines’ recent success has proven RNA technology works. RNA has the potential to be the
next wave in medical technology. It is a promising alternative to conventional vaccines and
therapeutics because of its:

  • safety (mRNA is a non-infectious, non-integrating platform)
  • high potency (mRNA can be made more stable and highly translatable, and can be
    administered repeatedly)
  • capacity for rapid development
  • potential for low-cost manufacture and safe administration.
    RNA vaccines and therapeutics have the potential to treat a range of human diseases, including:
  • cancer
  • rabies
  • zika
  • influenza
  • tuberculosis
  • HIV
  • malaria
  • cystic fibrosis
  • muscular dystrophy
  • cardiovascular disease.
    They may also be used in animal health, including to prevent clinical signs of animal diseases such as
    African swine fever and lumpy skin disease.
    Although there are many benefits to using RNA technology in vaccines and therapeutics, additional
    challenges must be considered. Manufacturing consistency, for both the mRNA and the lipid
    nanoparticles (LNP) is critical. New mRNA vaccines may pose challenges compared to other vaccine
    types due to, for example:
  • comparative reactogenicity
  • creation of multivalent products and comparative duration of protection
  • maintenance of cold chain in remote areas
  • regulatory issues for animal vaccines.
    RNA therapeutics could present additional technical and regulatory challenges as they may require
    higher (or more frequent) dosing, challenges of delivery to target organs and potential need for
    extra efficacy, safety and quality issues to be assessed.

As disastrous as the covid19 “vaccine” has been to public health with extraordinary excess deaths and Australian Senators exposing the collusion between regulatory bodies, pharmaceutical companies, the media, military and the government, it has not deterred the medical industrial complex from moving forward with plans to invest in mRNA based medicine research. This means that whether it’s cancer or childhood vaccination, medicine is moving to the mRNA based therapies.

The Australian Government’s partnership with Moderna and Victoria has primed the RNA sector for
growth. On 15 August 2022, the Australian Government finalised partnership arrangements with the
Victorian Government and pharmaceutical company Moderna to support establishment of
Moderna’s Australian mRNA production facility.

This mRNA facility will begin operations in late 2024 (subject to regulatory approvals) at Monash University’s Clayton Campus in Victoria.
This marked the beginning of another chapter for Australia’s RNA sector.

Australia will be one of few countries in the world – and the first country in the southern hemisphere
– with a commercial mRNA manufacturing capability supported by Australia’s strong track record of
expertise throughout the RNA value chain. It will give Australia greater certainty and faster access to
vaccines and could reduce the social and economic costs of future pandemics. The partnership also
signals the Australian Government’s strong support for rebuilding onshore advanced manufacturing,
sovereign capability and highly skilled local jobs.

The Moderna partnership is already having an impact and will encourage further development of
Australia’s broader RNA sector and next generation RNA technology.” End quote.


It is important to understand that the mass ‘vaccination” for COVID19 was a trial for mRNA technology in humans. It was only in 2023, that stage 3 trials were completed. Normally, the public would only begin to use drugs or vaccines that are in Stage 4 clinical trials.

The animals trials for coronavirus vaccines have always failed because the animals got sick and/or died :  

Studies in

Ferrets : https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035421

Cats: https://www.jstage.jst.go.jp/article/jvms/60/1/60_1_49/_article

Mice : https://pubmed.ncbi.nlm.nih.gov/22536382/


Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV in mice study https://pubmed.ncbi.nlm.nih.gov/18941225/


From the recently released South African contracts. Link to full contract https://healthallianceaustralia.org/wp-content/uploads/2023/09/OCRPfizer-1_Redacted-2.pdf

A South African court ordered Pfizer to release the contract between themselves and the South African government. The contract would be very similar to contracts signed around the world. 

This contract was signed on March 30th, 2021. Thus, it was known and agreed to by the purchasers then that

(1) Vaccine efficacy was UNKNOWN
(2) Vaccine adverse events were UNKNOWN
(3) Vaccine long term side-effects were UNKNOWN

Australians and people around the world were mandated to get an experimental jab and marketed the safe and effective message that was completely untrue.


This link will lead you to the Australian government website where you can provide feedback on the proposed adoption of the international health regulations.

The WHO wants to move from being an advisory body to a legislative board, giving themselves extraordinary powers whenever an emergency is declared.

Australia is a member state, that has already met to discuss initial views and priorities for a draft pandemic instrument text and proposed changes to the IHR.

The Australian government is currently seeking the views of Australian stakeholders and the community through
this online survey on what you want to see in a new pandemic instrument and amended IHR.

The Department may not accept:

  • submissions provided outside of this online survey;
  • submissions which contain offensive or defamatory comments, or which are outside the scope of the consultation;
  • submissions included as attachments (however, the Department may accept attachments that enhance text box responses and are explanatory); and
  • comments received after the consultation deadline (11.59PM AEST on 24 September 2023)

It is important to understand how the IHR, mRNA investments in Australia are all connected. A declaration of a pandemic by the WHO, (if it is becomes a legislative body) then becomes a vehicle to develop, distribute and potentially mandate “vaccines”, plus any other restrictions including border restrictions, quarantining, mask mandates, lock downs, business and school closures, etc..

The only people who can stop this are the Australian people, through non compliance, political lobbying and legal action. We need to raise awareness of these issues and that Australians do not want to be guinea pigs in the mRNA medical experiment. We don’t want billions of dollars wasted by government on unproven technology.


Health Alliance Australia raises awareness, provide educational material, support practitioners, and help those who have been adversely affected by the covid19 vaccines and mandates, but we can’t do it without your support! By providing a professional and educated response to health related issues, and forming a counter narrative to destructive public health measures, our measured approach will stay the course and lead to positive social change in due course.

Additionally help us raise funds to fund litigation to achieve the goal of returning our sovereign rights and freedom of choice through the legal system.

We are also deeply concerned by the WHO Pandemic Treaty, amendments to the International Health Regulations, and other changes to Australian law that provide the mechanism of absolute control, which could include more lock downs, vaccine mandates, restrictions, masking, discrimination based on vaccine status, public health measures like restrictions on public gatherings, border closures, quarantining and travel restrictions. Mandates continue to be enforced in many industries in Australia and this is unacceptable.

For this reason, we encourage you to make a donation or a monthly subscription. It is a small price to pay to in the fight for justice and truth.

Please share this article widely.

To top